APA aipamena

Kümler, I., Balslev, E., Stenvang, J., Brünner, N., Ejlertsen, B., Jakobsen, E. H., & Nielsen, D. L. (2019). Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene. BMC Cancer.

Chicago Style aipamena

Kümler, Iben, Eva Balslev, Jan Stenvang, Nils Brünner, Bent Ejlertsen, Erik Hugger Jakobsen, and Dorte Lisbet Nielsen. "Two Open-label, Single Arm, Non-randomized Phase II Studies of Irinotecan for the Treatment of Metastatic Breast Cancer in Patients With Increased Copy Number of the Topoisomerase I Gene." BMC Cancer 2019.

MLA aipamena

Kümler, Iben, et al. "Two Open-label, Single Arm, Non-randomized Phase II Studies of Irinotecan for the Treatment of Metastatic Breast Cancer in Patients With Increased Copy Number of the Topoisomerase I Gene." BMC Cancer 2019.